Related Experiment Video

Updated: Jun 17, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

10.9K

Refining the role of N6-methyladenosine in cancer

Jonas Koch1, Frank Lyko1

  • 1Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120 Heidelberg, Germany.

Current Opinion in Genetics & Development
|August 7, 2024
PubMed

Insights

N6-methyladenosine (m6A) RNA modification impacts cancer. New antibody-independent methods are needed to study m6A in cancer, and METTL3 targeting requires refinement for effective cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • N6-methyladenosine (m6A) is the most prevalent internal modification in eukaryotic messenger RNAs (mRNAs).
  • m6A influences mRNA metabolism and plays critical roles in physiological and pathological processes, including cancer.
  • Altered m6A patterns are linked to oncogenic phenotypes in various cancers.

Purpose of the Study:

  • To highlight the limitations of current antibody-dependent m6A detection methods in cancer research.
  • To emphasize the need for novel, antibody-independent, quantitative approaches for analyzing the cancer m6A landscape.
  • To discuss the therapeutic potential and challenges of targeting the m6A writer METTL3 in cancer.

Main Methods:

  • Review of existing literature on m6A modification, cancer, and therapeutic strategies.
  • Discussion of limitations associated with antibody-dependent m6A detection.
  • Exploration of antibody-independent quantitative methods for m6A analysis.

Main Results:

  • Current m6A detection methods in cancer research have significant limitations.
  • New quantitative, antibody-independent techniques are crucial for advancing m6A cancer studies.
  • Targeting METTL3 shows promise but requires therapeutic strategy refinement due to its essential role in healthy cells.

Conclusions:

  • Accurate assessment of the m6A landscape in cancer necessitates advanced, antibody-independent detection methods.
  • Targeting m6A pathways, specifically METTL3, offers therapeutic potential but demands careful optimization for cancer treatment.
  • Further research is required to develop precise therapeutic strategies for m6A-related cancer therapies.

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.3K
Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis08:50

Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis

Published on: May 14, 2020

6.6K

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.4K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K